PD-L1 as a biomarker of response to immune-checkpoint inhibitorsDeborah B. Doroshow, Fred R. Hirsch, Sheena Bhalla et al.|Nature Reviews Clinical Oncology|2021Cited by 1.5k
Innate Immune Landscape in Early Lung Adenocarcinoma by Paired Single-Cell AnalysesYonit Lavin, Miriam Mérad, Andrew M. Leader et al.|Cell|2017Cited by 1.2k
Interstitial lung abnormalities detected incidentally on CT: a Position Paper from the Fleischner SocietyHiroto Hatabu, David A. Lynch, Gary M. Hunninghake et al.|The Lancet Respiratory Medicine|2020Cited by 575
Single-cell analysis of human non-small cell lung cancer lesions refines tumor classification and patient stratificationAndrew M. Leader, Miriam Mérad, John A. Grout et al.|Cancer Cell|2021Cited by 349
The Role of Inflammation and Fibrosis in Interstitial Lung Disease Treatment DecisionsJürgen Behr, Athol U. Wells, Margaret L. Salisbury et al.|American Journal of Respiratory and Critical Care Medicine|2024Cited by 38